Wilmer Cutler Pickering Hale and Dorr represented Nuvalent, Inc. in the offering, and Simpson Thacher & Bartlett represented the underwriters. Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage...
Nuvalent’s $575 Million Common Stock Offering
Nuvalent’s Establishment and Prosecution of Global Patent Portfolios
Jones Day advised Nuvalent on the deal. Nuvalent, Inc. announced the establishment and prosecution of global patent portfolios related to small molecule ROS1-selective inhibitors, ALK-selective inhibitors, and...